Data#3 hits a record high: is the AI tailwind already priced in?

Data#3 surged 14.67% to an AUD 10.79 record on FY2026 results, with AI solutions up 100%+ and EBIT rising 16.6% (vs. revenue growth of 12.7%). Despite the growth, a fair-value model estimates intrinsic value at AUD 9.00, implying 16.6% downside from current levels as the stock is priced at 29.8x trailing earnings with ~10% gross margins. Technicals are stretched (StochRSI 100; RSI 67.5) after +50.9% over 6 months, so the article frames the “AI winner” narrative as potentially overdone for a low-margin distributor.

Analysis

Data#3 looks like the kind of AI beneficiary the market loves to overpay for: a downstream reseller with improving mix, but no real pricing power. The important mechanism is that AI demand is being monetized upstream by Microsoft and the hyperscalers, while the distributor is left with thinner take-rate economics; that makes EPS highly sensitive to even small changes in vendor incentives, discounting, or implementation mix. In other words, the stock can rerate on growth, but the business quality does not rerate with it.

Near term, momentum can persist because the name screens as a clean, debt-free AI proxy with a yield, but that is exactly why crowded ownership risk matters. When a low-margin model trades at a premium multiple, the first derivative of growth is what counts: if Azure/AI consumption decelerates even modestly or Microsoft tightens channel economics, the earnings multiple can compress quickly. The second-order winner is MSFT, not DTATF; the second-order loser is any regional IT distributor or systems integrator that relies on similar enterprise AI/endpoint demand but lacks scale.

Contrarian take: the market may be underestimating the durability of Australian enterprise AI adoption, but it is probably overestimating how much of that value accrues to the middleman. The real test over the next 1-3 months is whether FY2027 guidance absorbs the new investment drag without a margin reset. If management keeps raising revenue but not EBIT, the valuation case breaks; if the stock can hold the prior breakout after the next guidance update, the trend remains intact, but upside from here is likely capped without another estimate revision cycle.

Key Decisions for Investors

• Underweight/short DTATF on strength for a 1-3 month mean-reversion trade; risk/reward favors a move back toward intrinsic value unless FY2027 guidance is raised again. Falsifier: another upward EBIT revision or sustained break above the recent high with expanding margins.
• Prefer long MSFT over DTATF as the cleaner AI monetization trade over 6-12 months; hyperscaler consumption captures recurring spend and pricing power that the distributor does not. Use any DTATF strength as a relative-value entry point for the pair.
• Set a watch item on Microsoft channel incentives and Azure consumption growth: if partner rebates or consumption growth roll over, DTATF's earnings leverage should compress faster than the market expects. This is the key catalyst that would validate a short.
• Avoid chasing DTATF after the breakout unless the next quarter shows EBIT growing faster than revenue again; otherwise the stock is a low-margin toll road priced like a platform. If holding for yield, size small and treat it as a defensive income position, not an AI growth compounder.